Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKAR...

FDA Recall #D-0224-2025 — Class II — January 21, 2025

Recall #D-0224-2025 Date: January 21, 2025 Classification: Class II Status: Ongoing

Product Description

Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-442-15

Reason for Recall

Out of Specification for Dissolution

Recalling Firm

AvKARE — Pulaski, TN

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

341 cartons

Distribution

Nationwide in the USA

Code Information

Lot 45279, Exp 03/31/2025

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated